Reply to 'Rituximab in CD20 positive multiple myeloma' by P Moreau et al

Leukemia. 2008 Jan;22(1):214-5. doi: 10.1038/sj.leu.2404972. Epub 2007 Oct 11.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / metabolism*
  • Antineoplastic Agents / therapeutic use*
  • Gene Expression Regulation, Neoplastic / immunology
  • Humans
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / immunology
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antineoplastic Agents
  • Rituximab